Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04928456 · ClinicalTrials.gov registry record · NA

Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps

A NA study of Covid19, sponsored by Western University of Health Sciences.

Completed
Registry status
NA
Development phase
92
Enrollment target
1
Study location

NCT04928456 is a NA study of Covid19 that has completed, run by Western University of Health Sciences. The registered enrollment target is 92 participants, below the 2,701-participant average among 94 other Covid19 trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04928456, a NA study of Covid19, has completed, sponsored by Western University of Health Sciences.

COMPLETED
Registry status
NA
Development phase
92 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effectiveness of utilizing Osteopathic Manipulative Treatment (OMT) procedures as an addition to current mRNA COVID-19 vaccines in terms of enhancing the immune response of participants as assessed by looking for increased levels and duration of antibody titers.

Conditions Studied

Interventions

  • OTHER Osteopathic Manipulative Treatment (OMT)

Study Locations (1)

California

  • Western University of Health Sciences - Pomona

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2021-06-11
Est. Completion 2022-12-05
Phase NA

What the Registry Record Tells You About NCT04928456

The ClinicalTrials.gov registry entry for NCT04928456 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,701-participant average among 94 other Covid19 trials with a reported enrollment target (97% lower). The listed sponsor is Western University of Health Sciences, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which Osteopathic Manipulative Treatment (OMT) is the first listed.

NCT04928456 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04928456 about?

NCT04928456 is a clinical study titled "Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps". This study will evaluate the effectiveness of utilizing Osteopathic Manipulative Treatment (OMT) procedures as an addition to current mRNA COVID-19 vaccines in terms of enhancing the immune response of participants as assessed by looking for increased levels and duration of antibody titers.

What is the current status of trial NCT04928456?

This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2021-06-11. Estimated completion is 2022-12-05.

What conditions does trial NCT04928456 study?

This clinical trial studies the following conditions: Covid19.

What interventions are being tested in trial NCT04928456?

The interventions under investigation include: Osteopathic Manipulative Treatment (OMT) (OTHER).

Who is sponsoring clinical trial NCT04928456?

This trial is sponsored by Western University of Health Sciences, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04928456 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Covid19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.